FCA: forget chemoimmunotherapy with alemtuzumab?

Blood. 2012 May 31;119(22):5059-60. doi: 10.1182/blood-2012-04-413096.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
  • Male